The address of the principal business office of NEA 14, each Control Entity and Sandell is New Enterprise Associates, 1954 Greenspring Drive, Suite 600, Timonium, MD 21093. The address of the principal business office of Makhzoumi is New Enterprise Associates, 2855 Sand Hill Road, Menlo Park, CA 94025. The address of the principal business office of Florence is New Enterprise Associates, 104 5th Avenue, 19th Floor, New York, NY 10011.

The principal business of NEA 14 is to invest in and assist growth-oriented businesses located principally in the United States. The principal business of NEA Partners 14 is to act as the sole general partner of NEA 14. The principal business of NEA 14 LTD is to act as the sole general partner of NEA Partners 14. The principal business of each of the Florence, Makhzoumi and Sandell is to manage the Control Entities, NEA 14 and a number of affiliated partnerships with similar businesses.

During the five years prior to the date hereof, none of the Reporting Persons has been convicted in a criminal proceeding or has been a party to a civil proceeding ending in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

During the five years prior to the date hereof, none of the Reporting Persons has been convicted in a criminal proceeding or has been a party to a civil proceeding ending in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Each of NEA 14 and NEA Partners 14 is a Cayman Islands exempted limited partnership. NEA 14 LTD is a Cayman Islands exempted company. Florence, Makhzoumi and Sandell are each a United States citizen.

Not applicable.

As previously disclosed by the Issuer, on July 28, 2026, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, Caldera Therapeutics, Inc. ("Caldera"), Sonic Holdco, Inc. ("Parent"), Yellowstone Merger Sub, Inc., a direct, wholly owned subsidiary of Parent ("Caldera Merger Sub"), and Sonic Merger Sub, Inc., a direct, wholly owned subsidiary of Parent ("Synlogic Merger Sub"). Pursuant to the Merger Agreement, and upon the terms and subject to the satisfaction of the conditions described therein, the Issuer will be merged with and into Synlogic Merger Sub, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Synlogic Merger"), and Caldera will be merged with and into Caldera Merger Sub, with Caldera surviving as a wholly owned subsidiary of Parent (the "Caldera Merger" and, together with the Synlogic Merger, the "Mergers"). Subject to the terms and conditions of the Merger Agreement, (a) at the effective time of the Caldera Merger (the "Caldera Effective Time") and following the conversion into shares of common stock of Caldera, $0.0001 par value per share ("Caldera Common Stock") of Caldera's (i) Series A Preferred Stock, $0.00001 par value per share, and (ii) Series A-1 Preferred Stock, $0.00001 par value per share, each then-outstanding share of Caldera Common Stock (excluding any shares of Caldera Common Stock held by stockholders who have exercised and perfected appraisal rights for such shares) will be converted into the right to receive a number of shares of common stock of Parent, $0.001 par value per share ("Parent Common Stock"), calculated in accordance with the applicable exchange ratio as set forth in the Merger Agreement and (b) immediately following the Caldera Effective Time, at the effective time of the Synlogic Merger, each then-outstanding share of Common Stock of the Issuer (excluding any shares of Common Stock held by stockholders who have exercised and perfected appraisal rights for such shares) will be converted into the right to receive a number of shares of Parent Common Stock, calculated in accordance with the applicable exchange ratio as set forth in the Merger Agreement. Concurrently with the execution of the Merger Agreement, NEA 14 and certain stockholders of the Issuer (each, a "Stockholder" and together, the "Stockholders") entered into support agreements (the "Support Agreements") in favor of Caldera, providing, among other things, that such Stockholders will vote all of their eligible shares of capital stock of the Issuer: (i) in favor of approving the Mergers and the other actions contemplated by the Merger Agreement and (ii) against any proposal made in opposition to, or in competition with, the Merger Agreement or the Mergers. The foregoing descriptions of the Merger Agreement and the Support Agreements are qualified in their entirety by reference to the full text of such agreements. The Merger Agreement and the form of Support Agreement are included as Exhibit 2.1 and Exhibit 10.1, respectively, of the Issuer's Form 8-K, filed with the Securities and Exchange Commission on July 29, 2026 (the "Form 8-K") and are incorporated herein by reference. NEA 14 now holds a total of 2,922,722 shares of Common Stock (the "NEA 14 Shares"). As a result of the Support Agreements, the Reporting Persons may be deemed to be members of a "group" with the parties to the Support Agreements.* * See the Schedule 13D or 13G (or an amendment thereto to the extent any material change in the facts set forth in any Schedule 13D or 13G previously filed by any other Stockholder has occurred) filed, or that the Reporting Persons anticipate will be filed, separately by each Stockholder, which includes, or will include, information regarding the other Stockholder's jurisdiction of organization, principal business and address of principal office.

NEA 14 is the record owner of the NEA 14 Shares. As the general partner of NEA 14, NEA Partners 14 may be deemed to own beneficially the NEA 14 Shares. As the sole general partner of NEA Partners 14, NEA 14 LTD may be deemed to beneficially own the NEA 14 Shares. As individual members of the Executive Committee, which committee has voting and dispositive power with respect to the NEA 14 Shares, each of Florence, Makhzoumi and Sandell may be deemed to beneficially own the NEA 14 Shares. Each Reporting Person disclaims beneficial ownership of the NEA 14 Shares other than those shares which such person owns of record. The percentage of outstanding Common Stock of the Issuer which may be deemed to be beneficially owned by each Reporting Person is set forth on Line 13 of such Reporting Person's cover sheet. Such percentage was calculated based on the 11,696,641 shares of Common Stock reported by the Issuer to be outstanding as of May 7, 2026, as reported on the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 14, 2026.

Regarding the number of shares as to which such person has: (i) sole power to vote or to direct the vote: See line 7 of cover sheets (ii) shared power to vote or to direct the vote: See line 8 of cover sheets (iii) sole power to dispose or to direct the disposition: See line 9 of cover sheets (iv) shared power to dispose or to direct the disposition: See line 10 of cover sheets.

Except as set forth in Item 4 above, none of the Reporting Persons has effected any transaction in the NEA 14 Shares during the last 60 days.

No other person is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of, Common Stock beneficially owned by any of the Reporting Persons.

As of April 1, 2026, each of Baskett and Kerins has ceased to beneficially own five percent (5%) or more of the Issuer's Common Stock.

The information provided and incorporated by reference in Item 4 is hereby incorporated by reference. In addition, on July 27, 2026, the Issuer entered into a warrant amending agreement (the "Warrant Amending Agreement") with NEA 14 that (i) reduced the exercise price of the NEA 14 Purchase Warrants (as defined in Amendment No. 4) to $0.70 per share and (ii) removed NEA 14's right to require the Issuer or a successor entity to redeem the NEA 14 Purchase Warrants for cash in an amount equal to the Black-Scholes Value (as defined in the NEA 14 Purchase Warrants) of the unexercised portion thereof, concurrently with or within 30 days following the consummation of a fundamental transaction. The form of Warrant Amending Agreement is included as Exhibit 10.6 of the Form 8-K and is incorporated herein by reference.

Exhibit 1 - Agreement regarding filing of joint Schedule 13D. Exhibit 2 - Power of Attorney regarding filings under the Securities Exchange Act of 1934, as amended.